About PathoIntern
Vision & Mission
Why PathoIntern exists, what it sets out to achieve, and the science behind it.
Vision
“No critical blood smear should wait for review.”
In pathology laboratories worldwide, blood smear review is one of the most cognitively demanding and time-sensitive tasks performed by skilled clinicians. As slide volumes grow 5–10% annually and pathologist workloads reach unsustainable levels, the risk of delayed review for critical findings — blast cells, hemoparasites, severe morphological abnormalities — increases correspondingly.
PathoIntern exists to close that gap: not by replacing pathologist expertise, but by ensuring that expertise is always applied first to the cases that need it most.
Mission
“To help pathologists prioritize blood smear slides through safe, non-diagnostic AI triage — so expertise is applied where it matters most.”
PathoIntern is designed to act as a digital intern — one that never sleeps, never fatigues, and never makes a final call. It performs first-pass analysis, surfaces anomalous patterns, and suggests priority order. The pathologist retains complete authority over every clinical decision.
Four Mission Pillars
First-Pass Analysis
CTransPath encodes each blood smear patch into a 768-dimensional morphological feature vector, providing a quantitative basis for prioritization without human intervention.
Priority by Anomaly Risk
k-NN anomaly detection scores each patch against a normal-cell baseline and maps the result to a 0–100 criticality score across four actionable tiers.
Incremental Learning
Pathologist verdicts (agree / disagree / modify) are captured with full attribution. These corrections feed future model improvement cycles, making the system smarter over time.
Transparent & Auditable
Every action — upload, embedding, score, review, verdict — is recorded in an immutable audit log. No unsupervised AI decision is ever made without a human in the loop.
Scientific Foundation
Four peer-reviewed publications ground the problem statement and technical approach:
Argument chain: The problem exists (Paper 1) → AI triage works without diagnosing (Paper 2) → CTransPath + anomaly detection is clinically validated (Paper 3) → Foundation model embeddings generalize across pathology tasks (Paper 4).